Evidence map›Paper›PMID 22945695›Full record

ArticleMammalian genome : official journal of the International Mammalian Genome Society2012

Neutral sphingomyelinase 2 deficiency is associated with lung anomalies similar to emphysema.

Christophe Poirier, Evgeny V Berdyshev, Christiana Dimitropoulou, Natalia V Bogatcheva, Paul W Biddinger, Alexander D Verin

Open access · greenAbstract read
In one paragraph

Article in Mammalian genome : official journal of the International Mammalian Genome Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Neutral sphingomyelinase-2 and cardiometabolic diseases.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2021
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury.American journal of physiology. Lung cellular and molecular physiology · 2014
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christophe PoirierVascular Biology Center, Georgia Health Sciences University, 1459 Laney-Walker Boulevard, CB-3701, Augusta, GA 30912, USA. cpoirier34@hotmail.com
Evgeny V Berdyshev
Christiana Dimitropoulou
Natalia V Bogatcheva
Paul W Biddinger
Alexander D Verin
Augusta University Health · USUniversity of Illinois Chicago · US

Funding

Microtubules in lung endothelial cell barrier regulationR01HL067307 · NHLBI · UNIVERSITY OF CHICAGO · PI VERIN, ALEXANDER D · 2001 to 2009
$2.5M
ATP in Lung Endothelial Barrier EnhancementR01HL083327 · NHLBI · UNIVERSITY OF CHICAGO · PI VERIN, ALEXANDER D · 2006 to 2009
$1.5M
ALK/SMAD Signaling in TGF beta-induced EC PermeabilityR01HL080675 · NHLBI · UNIVERSITY OF CHICAGO · PI VERIN, ALEXANDER D · 2005 to 2008
$1.5M
Signaling Sphingolipids in COPDR03HL095440 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BERDYSHEV, EVGENY V, PETRACHE, IRINA · 2008 to 2009
$169k
NHLBI NIH HHS R01 HL067307NHLBI NIH HHS R01HL067307NHLBI NIH HHS R01 HL080675NHLBI NIH HHS R01HL080675NHLBI NIH HHS R01 HL083327NHLBI NIH HHS R01HL083327NHLBI NIH HHS R03 HL095440NHLBI NIH HHS R03HL095440
6 · The paper itself

Abstract

Neutral sphingomyelinase 2 (nSMase2) upregulation was recently demonstrated to serve as a molecular link between smoke inhalation and emphysematous changes in lungs. Here we report that nSMase2 deficit impairs lung development in mice. We have shown previously that fragilitas ossium (fro) mice carry a mutation in the Smpd3 gene, rendering nSMase2 catalytically inactive. Analysis of lung phenotype revealed that fro mice have abnormally enlarged alveoli and increased compliance of the respiratory system, similar to morphological and functional manifestations of emphysema. Analysis of sphingolipid content in fro lungs revealed a decreased level of C14:0 ceramide but no significant alterations in the levels of sphingosine or sphingosine-1-phosphate. Altogether, our data suggest that nSMase2 activity and ceramide level are critical for lung development and function. Based on our data, ceramide can no longer be viewed as a lipid solely detrimental to lung function.

Indexed as

PhenotypeAnalysis of VarianceAnimalsCeramidesDNA PrimersGenotypeHistological TechniquesLungLung ComplianceMiceOsteogenesis ImperfectaPolymerase Chain ReactionSphingomyelin PhosphodiesteraseCeramidesDNA PrimersSmpd3 protein, mouseSphingomyelin Phosphodiesterase

Identifiers

PMID22945695
PMCPMC4046642
OpenAlexW1973967917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.